Kovesdy Csaba P, Anderson John E, Derose Stephen F, Kalantar-Zadeh Kamyar
Division of Nephrology, Salem VA Medical Center, 1970 Roanoke Boulevard, Salem, VA 24153, USA.
Clin J Am Soc Nephrol. 2009 May;4(5):973-8. doi: 10.2215/CJN.06031108. Epub 2009 Apr 15.
Blacks are over-represented among dialysis patients, but they have better survival rates than whites. It is unclear if the over-representation of blacks on dialysis is due to faster loss of kidney function or greater survival (or both) in predialysis stages of chronic kidney disease (CKD).
DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: We compared predialysis mortality, incidence of end stage renal disease (ESRD), and slopes of estimated GFR (eGFR) in 298 black versus 945 white male patients with moderate and advanced nondialysis-dependent CKD (NDD-CKD) from a single medical center. Mortality and ESRD incidence were compared in parametric survival models, and slopes of eGFR were assessed in mixed-effects models.
Blacks had lower crude mortality and higher crude ESRD incidence. The lower mortality in blacks was explained by differences in case mix, especially a lower prevalence of cardiovascular disease, and the higher incidence of ESRD was explained by differences in case mix and baseline kidney function. The slopes of eGFR were similar in blacks and whites.
Lower mortality in black versus white patients is also observed in NDD-CKD and can be accounted for by differences in clinical characteristics. Higher mortality of black patients in earlier stages of CKD may result in the selection of a subgroup with fewer comorbidities and better survival in later stages of CKD. The higher crude ESRD rate in blacks appears to result from lower mortality in late stages of CKD, not faster progression of CKD.
黑人在透析患者中所占比例过高,但他们的生存率高于白人。目前尚不清楚黑人在透析患者中所占比例过高是由于慢性肾脏病(CKD)透析前阶段肾功能丧失更快还是生存率更高(或两者兼有)。
设计、场所、参与者及测量方法:我们比较了来自单一医疗中心的298名黑人与945名白人男性中度和重度非透析依赖性CKD(NDD-CKD)患者的透析前死亡率、终末期肾病(ESRD)发病率以及估计肾小球滤过率(eGFR)的斜率。在参数生存模型中比较死亡率和ESRD发病率,并在混合效应模型中评估eGFR的斜率。
黑人的粗死亡率较低,粗ESRD发病率较高。黑人较低的死亡率可通过病例组合差异来解释,尤其是心血管疾病患病率较低,而较高的ESRD发病率可通过病例组合和基线肾功能差异来解释。黑人和白人的eGFR斜率相似。
在NDD-CKD患者中也观察到黑人患者的死亡率低于白人患者,这可以通过临床特征的差异来解释。CKD早期黑人患者较高的死亡率可能导致选择了一组合并症较少且CKD后期生存率较高的亚组。黑人较高的粗ESRD率似乎是由于CKD后期死亡率较低,而非CKD进展更快。